Navigation Links
Research finds finds potential treatment for drug-resistant H7N9 influenza virus
Date:1/16/2014

MANHATTAN, Kan. -- The novel avian H7N9 influenza virus has caused more than 130 human infections with 43 deaths in China. New research, conducted under the supervision of Kansas State University's Juergen Richt, is showing promise in helping to fight this deadly virus.

"Emergence of a novel drug-resistant H7N9 influenza virus: Evidence-based clinical potential of a natural IFN-alpha for infection control and treatment" is set to publish in an early online edition of January's Expert Review of Anti-infective Therapy journal.

Richt is a regents distinguished professor and Kansas Bioscience Authority eminent scholar at Kansas State University's College of Veterinary Medicine. He also is the director of the U.S. Department of Homeland Security's Center of Excellence for Emerging and Zoonotic Animal Diseases, or CEEZAD, at the university. The center is working with scientists at Hemispherx Biopharma Inc. to develop novel pharmacological treatments. Research for the H7N9 project was conducted at the university's Biosecurity Research Institute, primarily by Qinfang Liu, a postdoctoral fellow in diagnostic medicine and pathobiology in Richt's laboratory.

Richt is recognized as an expert on zoonotic agents and has published extensively on the monitoring of mutations and basic events leading to cross-species transmission of influenza viruses and the opportunities to adapt to human hosts, with the potential to cause a pandemic. Because of the lack of existing immunity against H7 subtype influenza viruses in the human population and the absence of a licensed commercial vaccine, antiviral drugs are critical tools for the treatment of human infections with this novel H7N9.

"Both M2-ion channel blockers, such as amantadine, and neuraminidase inhibitors, such as Tamiflu or Relenza, are used as antiviral drugs for influenza infections of humans," Richt said. "The emerging H7N9 viruses are resistant to the M2-ion channel blockers and s
'/>"/>

Contact: Juergen Richt
jricht@vet.k-state.edu
785-532-2793
Kansas State University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
2. Research reveals first evidence of hunting by prehistoric Ohioans
3. Diabetes Research Institute develops oxygen-generating biomaterial
4. APS issues new policy requiring identification of sex or gender in reporting scientific research
5. UC Santa Barbara researchers discover genetic link between visual pathways of hydras and humans
6. Study jointly led by UCSB researcher supports theory of extraterrestrial impact
7. U of Alberta researcher steps closer to understand autoimmune diseases
8. Research on flavanols and procyanidins provides new insights into how these phytonutrients may positively impact human health
9. A project to research biological and chemical aspects of microalgae to fuel approach
10. Scripps Research discoveries lead to newly approved drug for infant respiratory distress syndrome
11. Researchers attempt to solve problems of antibiotic resistance and bee deaths in one
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Mass. (September 15, 2014) The so-called central ... makes proteinhas long provided a simplified explanation for ... living organisms. , In reality, of course, ... schema first articulated nearly 60 years ago by ... double-helix structure. For one, there are multiple types ...
(Date:9/15/2014)... cell division has evolved a simple, mechanical solution ... the Sept. 11 Science Express. ... counts and misalignments that lead to infertility, miscarriage, ... cell division cause these problems, but what exactly ... Marston of the Wellcome Trust Center for Cell ...
(Date:9/15/2014)... that a single group of microorganisms may be responsible ... the oceans, with implications for the global carbon cycle ... essential molecule required by most life on this planet, ... of microorganisms because it is so large and complex. ... maintaining the brain and nervous systems, as well as ...
Breaking Biology News(10 mins):Scientists discover RNA modifications in some unexpected places 2Cells simply avoid chromosome confusion 2Cells simply avoid chromosome confusion 3Researchers discover new producer of crucial vitamin 2
... small number of households could go a long way to ... measured differences in energy demands at the household level, appears ... Dominik Saner and colleagues point out that the energy ... mobility needs accounts for more than 70 percent of emissions ...
... accurately, according to a new study by the late ... in Germany. Their analysis of human melody singing in ... work is published online in Springer,s journal Animal ... one of the most complex and demanding cognitive challenges ...
... Down syndrome, more commonly known as "trisomy 21" is ... population: Alzheimer,s disease, leukemia, or cardiac deficiency. In a ... Faculty of Medicine of the University of Geneva (UNIGE), ... 21, determining the risk of congenital heart disease in ...
Cached Biology News:Songbirds turn on and tune up 2Complex genetic architectures: Some common symptoms of trisomy 21 2
(Date:9/16/2014)... 2014 BlueInGreen® , a ... method for delivering dissolved gases into liquids, announced ... as a manufacturer’s representative firm to its sales ... for municipal water and wastewater applications in the ... was founded in 1992 and serves Quebec and ...
(Date:9/16/2014)... 16, 2014 CIRTEC Medical Systems’ Board ... as CEO of CIRTEC. , “I am delighted ... the Company.” noted Brian Highley. “The company has made ... strong organic growth over the past two years. The ... to improve and expand the services Cirtec offers its ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 ... initiatives to position themselves for their 89th ... labeling and encoding, Pharma Packaging Solutions is ... hardware and software and new procedures. Establishing ... Good Manufacturing Practices (cGMP), Pharma Packaging Solutions ...
(Date:9/16/2014)... Calif. , Sept. 16, 2014 /PRNewswire-iReach/ -- ... index (BMSi) test identifies patients with bone fragility ... Over 160 million people worldwide are at risk ... by today,s standard bone strength test, the DEXA ... 2014 American Society for Bone and Mineral Research ...
Breaking Biology Technology:BlueInGreen® Expands into Canada – Signs Representative Agreement with H2Flow Equipment Inc. 2Adding Serialization Capabilities and Expanded Capacity, Pharma Packaging Solutions Is Preparing for 89th Year of Business 2ActiveLife's BMSi Test Provides Hope for 160 Million with Undetectable Risk of Bone Fracture 2ActiveLife's BMSi Test Provides Hope for 160 Million with Undetectable Risk of Bone Fracture 3
... In light of an announcement made recently by Astellas Pharma ... that it had received a letter dated November 13, 2008 ... acquire CV Therapeutics at a price of $16.00 per share, ... After careful deliberation, with the assistance of its financial ...
... Alfacell Corporation (OTC Bulletin Board: ACEL) today reported that ... Food and Drug Administration (FDA) to discuss the company,s ... rolling New Drug Application (NDA) for the treatment of ... meeting, the FDA provided guidance to the company recommending ...
... Conference Call and Webcast Scheduled for Tuesday, February 3, ... (Nasdaq: NBIX ) announced today that the ... financial results after the Nasdaq market closes on Tuesday, ... conference call and webcast to discuss its financial results ...
Cached Biology Technology:CV Therapeutics Statement on Unsolicited Proposal From Astellas 2CV Therapeutics Statement on Unsolicited Proposal From Astellas 3Alfacell Provides ONCONASE(R) NDA Submission Update 2Alfacell Provides ONCONASE(R) NDA Submission Update 3Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2008 Financial Results 2
Goat polyclonal to Duffy / FY / DARC...
SMVT (N-14)...
... Description: Proteinase K is a ... wide range of applications purified from the fungus ... the carboxyl group of N-substituted hydrophobic aliphatic and ... as a serine protease. Proteinase K is useful ...
... The H2OBIT™ is a fully licensed, high throughput, ... processing of up to 24 microplates. This equates ... plates. A robotic arm rapidly transfers ... resulting in temperature ramping times that are considerably ...
Biology Products: